Delivery Order SPE2DB22D1002-SPE2DB24FLAJ9
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $36,672.18 contract is for the supply of Ozempic 0.25-0.5 mg/dose pen 3 ml, a medication used for diabetes management. This delivery order is placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,798.72, is for the procurement of Ozempic 0.25-0.5 mg/dose pens. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,302.30, is for the supply of Ozempic 0.25-0.5 mg/dose pens. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ozempic 0.25-0.5 mg/dose pen (3 mL), a medication used to treat type 2 diabetes. The Delivery Order has a ceiling value of $1,451.34 and a completion date of January 25, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,134.85, is for the supply of Ozempic 0.25-0.5 mg/dose pens, a medication used to treat type 2 diabetes. The contract has a firm fixed price pricing type and an ultimate completion date of May 31, 2024. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) held by...
- This is a $6,502.68 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ozempic 0.25-0.5 mg/dose pens, a medication used to treat diabetes. It has an ultimate completion date of March 18, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide...
- This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,611.86 delivery order is for Ozempic 0.25-0.5 mg/dose pens, a medication used to treat diabetes. The IDC has a ceiling value of $999,999,999 and runs through November 2026, providing a comprehensive range of pharmaceutical products and medical supplies to support military...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is valued at $4,633.60 and has an ultimate completion date of November 24, 2023. The contract provides OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a medication for diabetes management. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $75,829.14, is for the delivery of Ozempic 0.25-0.5 mg/dose pens. The contract has an ultimate completion date of March 31, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $7,500.72 firm fixed price delivery order to AmerisourceBergen Drug Corp for Ozempic 0.25-0.5 mg/dose pens (3mL) on April 24, 2025, with completion scheduled for April 25, 2025. This non-set-aside contract was competitively awarded and performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a relatively small-value transaction for a brand-name diabetes medication to support federal medical supply needs. This...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB24FLAJ9Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,451.30 delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens, a prescription medication used to treat type 2 diabetes. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This delivery order does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 4/8/24 |